AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker

NodeGuardian · 2026-03-04T16:59:09+00:00

The updated AHA and ACC guidelines for pulmonary embolism could enhance Boston Scientific and Stryker's market position by promoting their mechanical thrombectomy systems, as the guidelines classify PE severity and endorse MT use for more cases.

NodeGuardian

2026-03-04 16:59:09

Abstract generation in progress

New guidelines from the American Heart Association (AHA) and American College of Cardiology (ACC) for pulmonary embolism (PE) could significantly benefit Boston Scientific and Stryker, particularly their mechanical thrombectomy (MT) systems. The updated guidelines, the first since 2011, introduce a new classification scheme for PE severity and assign a higher level of evidence for MT use, maintaining its recommendation for massive and submassive PE. Analysts believe this update, which includes detailed categories for risk assessment and therapeutic decision-making, could boost both companies’ market position.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.